Chronic low-grade inflammation, often called "inflammaging," is now recognized as a central driver of biological aging, contributing to cardiovascular disease, neurodegeneration, insulin resistance, and loss of muscle mass
For a detailed overview of how Australian peptide regulation works, see our guide to peptide legality and TGA compliance in Australia
Dodatkowo N-aminowy koniec peptydu jest poddany N-acetylacji, a koniec C-karboksylowy peptydu jest amidowny
Your personal schedule will depend on the peptides used, your health history, lab results when needed, and how your body responds during your treatment cycle
Avoid vials showing loose, melted, or yellowed powder layers, which reveal a compromised seal